FREEMAN KEVIN D 4/A
4/A · GALECTIN THERAPEUTICS INC · Filed Dec 15, 2021
Insider Transaction Report
Form 4/AAmended
FREEMAN KEVIN D
Director
Transactions
- Purchase
Common Stock
2021-12-15$2.28/sh+5,000$11,400→ 50,000 total(indirect: By LLC)
Holdings
- 23,469
Common Stock
- 16,000(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.